Furuki, Takayuki
32  results:
Search for persons X
?
 
?
3

The concomitant use of sodium-glucose co-transporter 2 inhi..:

Kobayashi, Kazuo ; Toyoda, Masao ; Hatori, Nobuo...
Cardiovascular Endocrinology & Metabolism.  12 (2023)  4 - p. e0292 , 2023
 
?
 
?
7

Polypharmacy influences the renal composite outcome in pati..:

Kobayashi, Kazuo ; Toyoda, Masao ; Hatori, Nobuo...
Clinical and Translational Science.  15 (2022)  4 - p. 1050-1062 , 2022
 
?
8

Comparison of renal outcomes between sodium glucose co-tran..:

Kobayashi, Kazuo ; Toyoda, Masao ; Hatori, Nobuo...
Diabetes Research and Clinical Practice.  185 (2022)  - p. 109231 , 2022
 
?
11

Sodium–glucose cotransporter 2 inhibitor‐induced reduction ..:

Kobayashi, Kazuo ; Toyoda, Masao ; Hatori, Nobuo...
Journal of Diabetes Investigation.  12 (2021)  8 - p. 1408-1416 , 2021
 
?
12

Blood pressure after treatment with sodium–glucose cotransp..:

Kobayashi, Kazuo ; Toyoda, Masao ; Hatori, Nobuo...
Journal of Diabetes Investigation.  12 (2020)  1 - p. 74-81 , 2020
 
?
13

The influence of long‐term administration of SGLT2 inhibito..:

Furuki, Takayuki ; Kobayashi, Kazuo ; Toyoda, Masao...
The Journal of Clinical Hypertension.  22 (2020)  12 - p. 2306-2314 , 2020
 
1-15